The heterogeneous nature of the mechanisms underlying neuropathic pain complicates the selection of appropriate treatments for individual patients. Although systematic reviews have outlined the ...

Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...

“By adding post-surgical neuropathic pain to the US label if results are positive, we would have the potential to fill an ...

Neck pain, shoulder pain, back pain, arm pain — these can all be caused by a herniated disc — if left untreated, it can become debilitating and lead to nerve damage. Now, a new procedure is helping to ...

These unexplained cases are called cryptogenic sensory polyneuropathy (CSPN), where the cause of the nerve pain remains unknown. For people with CSPN, finding effective treatment can be ...

Boston Children's Hospital and Harvard Medical School researchers have discovered a neuroimmune communication pathway that ...

The efficacy of pregabalin for the management of neuropathic pain associated ... Patients in both treatment groups had significantly reduced mean pain scores and experienced less pain while ...

A team of international researchers, including scientists from the University of Adelaide, has developed a new approach to pain relief using a well-known chemical reaction. This new method, which ...

A team of international researchers including those from the University of Adelaide have taken a well-known chemical reaction ...

The Phase III trial AV001 aims to evaluate QUTENZA in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures ...

Pain-sensing neurons exchange signals with immune cells that drive endometriosis, sparking the pain associated with the condition, new research suggests.